SCHEMBL2807935

SCHEMBL2807935

COC(=O)c1ccc(C(=N)NO)c(OC)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.54
KMT2A Q03164 4/20 0.49
KDM4E B2RXH2 8/20 0.49
ALDH1A1 P00352 6/20 0.49
HSD17B10 Q99714 4/20 0.49
HPGD P15428 3/20 0.49
ATM Q13315 2/20 0.49
GAA P10253 2/20 0.49
GLA P06280 1/20 0.49
CASP1 P29466 1/20 0.49
CASP7 P55210 1/20 0.49
TSHR P16473 2/20 0.46
MEN1 O00255 2/20 0.46
LMNA P02545 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
CA1 P00915 2/20 0.45
CA2 P00918 2/20 0.45
CA12 O43570 1/20 0.45
CA7 P43166 1/20 0.45
XDH P47989 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2804881 0.88 KDM4E (0.47) MAPTKMT2AKDM4EALDH1A1HSD17B10
SCHEMBL6918212 0.84 MAPT (0.57) MAPTKMT2AKDM4EALDH1A1HSD17B10
SCHEMBL2892480 0.83 MAPT (0.64) MAPTKMT2AKDM4EALDH1A1HSD17B10
SCHEMBL20608788 0.81 ALDH1A1 (0.49) MAPTKMT2AKDM4EALDH1A1HSD17B10
SCHEMBL4392531 0.81 KDM4E (0.49) MAPTKMT2AKDM4EALDH1A1HSD17B10
SCHEMBL644612 0.80 MAPT (0.60) MAPTKMT2AKDM4EALDH1A1HSD17B10
SCHEMBL2406876 0.80 MAPT (0.60) MAPTKMT2AKDM4EALDH1A1HSD17B10
SCHEMBL21434946 0.79 ALDH1A1 (0.46) MAPTKMT2AKDM4EALDH1A1HSD17B10
SCHEMBL31610822 0.78 MAPT (0.50) MAPTKMT2AKDM4EALDH1A1HSD17B10
SCHEMBL30959745 0.78 MAPT (0.57) MAPTKMT2AKDM4EALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2193125-B1 OXADIAZOLE DERIVATIVES MERCK SERONO SA (CH) 2017-01-11 EP disclosed
US-8202865-B2 Oxadiazole derivatives MERCK SERONO SA (CH) 2012-06-19 US disclosed
US-20100240658-A1 Oxadiazole Derivatives MERCK SERONO SA (CH) 2010-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240658-A1 Oxadiazole Derivatives OXA1L, RO60, NQO2 MAPT 3455/4885KMT2A 1416/4885KDM4E 815/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.